Gravix. Clinical reference

How we review

How a Gravix page is checked

A page is not published because it sounds complete. It is published when each number can be pointed at a label, a WHO sheet, or a named trial.

1. Open the primary file

Work starts with the current FDA label or DailyMed set, WHO sheets where they apply, EMA assessments, guideline statements, and named randomized trials. A blog summary is a pointer to the original, not a source we quote.

2. One section, one fact card

Each chapter is built from a short list of claims. Dose, half-life, and trial percents stay off the page unless they sit on that card. If the evidence is thin, the sentence stays qualitative. Ivermectin pages are the test of that rule: a negative large trial is reported as a negative large trial.

3. Different chapter order per URL

The middle of a medicine page is not a shared skeleton. Opening context and the last safety close stay easy to find. Everything between them is written for that slug, with its own H2 wording.

4. Elena Marchetti reads the draft

She checks accuracy, walks the safety lines, and writes the reader replies. Her name and profile travel with the finished URL.

5. The two rules we will not soften

External links go to named organisations and carry nofollow. Tadalafil, sildenafil and vardenafil are never combined with a nitrate. Ivermectin is not treated as a proven COVID medicine on this site.

6. The date on the page

Each page shows when it was last opened. If a label moves, write [email protected] and we will reopen the file.

Last Updated

Gravix Pharma

Five medicines. Label doses. Named trials.

Each page starts from DailyMed or SmPC and a study with a name. Elena Marchetti writes the reader replies. Nothing is sold.

Browse the drugs